Literature DB >> 31255378

Markers of iron status, blood pressure and incident hypertension among Chinese adults.

Yongjian Zhu1, Gaiyun Chen2, Yacong Bo3, Yanhua Liu4.   

Abstract

BACKGROUND AND AIMS: The evidence on the relationship between markers of iron, blood pressure and hypertension are limited and inconsistent. This prospective cohort study aimed to investigate the relationship of serum ferritin (SF), transferrin, soluble transferrin receptor (sTFR) and haemoglobin on blood pressure and incident hypertension in the China Health and Nutrition Survey (CHNS) study. METHODS AND
RESULTS: We studied 8337 adults aged 18 years old or above from CHNS in 2009 to investigate the association of markers of iron and blood pressure (BP). Among them, 4509 non-hypertensive participants who completed follow up were included to investigate the association of markers of iron and hypertension development. Linear regression model was used to assess the association between markers of iron and BP. Cox regression model was used to examine the association of markers of iron and hypertension development. SF and serum sTFR concentration had a non-significant effect on incident hypertension. Transferrin and haemoglobin concentrations were positively associated with incident hypertension. Compared to the participants with the lowest tertile of transferrin, those with the highest tertile had a higher risk of developing hypertension [HR: 1.26, 95% CI (1.04, 1.53), P = 0.017]. Similarly, participants with the highest tertile of haemoglobin had a significantly higher risk of incident hypertension [HR: 1.27, 95% CI (1.01, 1.59), P = 0.038].
CONCLUSION: The current study found that haemoglobin and transferrin levels were positively associated with blood pressure and incident hypertension. Further research in different ethnic groups is required to confirm the association of the full range of markers of iron with BP and incident hypertension.
Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Haemoglobin; Hypertension; Serum ferritin; Soluble transferrin receptor; Transferrin

Mesh:

Substances:

Year:  2019        PMID: 31255378     DOI: 10.1016/j.numecd.2019.04.012

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.666


  9 in total

1.  Association between high serum Nogo-B and hypertension in Chinese Han.

Authors:  Shunuo Li; Jianmeng Zheng; Xiaoxia Dong; Shasha Bi; Liqin Duan; Wei Zheng; Peishi Yan
Journal:  BMC Cardiovasc Disord       Date:  2022-06-03       Impact factor: 2.174

2.  Increased Serum Soluble Transferrin Receptor Levels Were Associated With High Prevalence of Cardiovascular Diseases: Insights From the National Health and Nutrition Examination Survey 2017-2018.

Authors:  Shiyu Zhu; Chang Liu; Chengchen Zhao; Guanzhong Chen; Simin Meng; Ma Hong; Meixiang Xiang; Yao Xie
Journal:  Front Cell Dev Biol       Date:  2022-04-12

3.  Exploring biomarkers associated with deteriorating vascular health using a targeted proteomics chip: The SABPA study.

Authors:  Anna Dieden; Leone Malan; Catharina M C Mels; Leandi Lammertyn; Annemarie Wentzel; Peter M Nilsson; Petri Gudmundsson; Amra Jujic; Martin Magnusson
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 4.  Iron in Cardiovascular Disease: Challenges and Potentials.

Authors:  Shizhen Li; Xiangyu Zhang
Journal:  Front Cardiovasc Med       Date:  2021-11-30

5.  Quantitative susceptibility mapping to evaluate brain iron deposition and its correlation with physiological parameters in hypertensive patients.

Authors:  Xin Li; Dayong Jin; Yinhu Zhu; Liyao Liu; Yanqiang Qiao; Yifan Qian; Juan Tian; Boyuan Jiang; Chunkai Hou; Jigang Geng; Xiaoshi Li; Xiaohua Gao; Yongli Ma; Shaoyu Wang; Jianhai Zong; Yue Qin
Journal:  Ann Transl Med       Date:  2021-10

6.  Maternal Iron Status in Early Pregnancy and Blood Pressure Throughout Pregnancy, Placental Hemodynamics, and the Risk of Gestational Hypertensive Disorders.

Authors:  Minerva J Taeubert; Clarissa J Wiertsema; Marijn J Vermeulen; Hugo G Quezada-Pinedo; Irwin K Reiss; Martina U Muckenthaler; Romy Gaillard
Journal:  J Nutr       Date:  2022-02-08       Impact factor: 4.798

7.  Appraising the Causal Association between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study.

Authors:  Xingchen Wang; Xizhi Wang; Yingchao Gong; Xiaoou Chen; Danfeng Zhong; Jun Zhu; Lenan Zhuang; Jing Gao; Guosheng Fu; Xue Lu; Dongwu Lai
Journal:  Nutrients       Date:  2022-08-09       Impact factor: 6.706

Review 8.  Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases.

Authors:  Fang Yan; Kaifeng Li; Wenjuan Xing; Mingqing Dong; Mingliang Yi; Haifeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-09-07       Impact factor: 7.310

9.  (-)-Epicatechin Reduces the Blood Pressure of Young Borderline Hypertensive Rats During the Post-Treatment Period.

Authors:  Michal Kluknavsky; Peter Balis; Martin Skratek; Jan Manka; Iveta Bernatova
Journal:  Antioxidants (Basel)       Date:  2020-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.